ArticleJSES international2026
Axillary nerve palsy incidence after total shoulder arthroplasty with and without neuromuscular blockade.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Axillary nerve palsy is a rare but significant complication of shoulder arthroplasty. The axillary nerve lies just beneath the inferior glenoid, increasing susceptibility to traction and compression injures during surgery. Neuromuscular blocking agents are commonly used to facilitate exposure and dissection but may reduce the surgeon's ability to perceive excessive traction or tension on the nerve. The aims of this study are twofold, to (1) determine whether intraoperative paralytic use is associated with post-operative axillary nerve palsy and (2) assess its relationship with operative time. Methods: A retrospective study was conducted of patients that underwent anatomic total shoulder arthroplasty and reverse total shoulder arthroplasty between 2015 and 2024 at a single health-care center. Exclusion criteria included hemiarthroplasty, prior ipsilateral open shoulder surgery, pre-existing axillary nerve deficits, and lack of documented three months axillary nerve examination. Of 2,303 eligible patients, 397 were excluded, leaving 1906 patient for primary analysis. Collected variables included demographics, comorbidities, American Society of Anesthesiologist classification, and paralytic use. Outcomes assessed were post-operative axillary nerve palsy at three months and operative duration. Results: Among 1,906 patients included in the primary analysis, 1,398 (73.3%) received intraoperative paralytics. Post-operative axillary nerve palsy occurred in 17 patients (0.9%). Among patients who did not receive paralytics, 0.4%, developed axillary nerve palsy, compared to 1.1% who received paralytics ( Conclusion: In this large retrospective study, intraoperative paralytic use was not associated with a higher risk of axillary nerve palsy but was linked to a significant 18.3 minutes reduction in operative time. These findings suggest that paralytic use may enhance surgical efficiency without increasing post-operative nerve injury. However, given the low incidence of palsy and the retrospective nature design, further studies are warranted to confirm these associations and their clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.